Gut microbiota in health and disease: An overview focused on metabolic inflammation

Beneficial Microbes

Volumn 7, Issue 2, 2016, Pages 181-194

  Nagpal, R ^a   Kumar, M ^b   Yadav, A K ^b   Hemalatha, R ^b   Yadav, H ^c   Marotta, F ^d   Yamashiro, Y ^a  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF NUTRITION   (India)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d ReGenera Aging Intervention Research Group   (Italy)

Author keywords

Intestinal microbiota; Metabolic syndrome; Obesity; Probiotics; Type 2 diabetes

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT;

ACTINOBACTERIA; ACUTE DIARRHEA; BACTERIAL LOAD; BACTEROIDETES; CONSTIPATION; DIET; DIGESTION; DISEASE COURSE; DISEASE PREDISPOSITION; ENDOTOXEMIA; ENTERITIS; FIRMICUTES; FOOD ALLERGY; FUSOBACTERIA; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INSULIN RESISTANCE; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; IRRITABLE COLON; LIFESTYLE; LIVER DISEASE; METABOLIC SYNDROME X; METABOLOMICS; METAGENOMICS; MICROBIAL COMMUNITY; MICROBIAL METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PERMEABILITY BARRIER; PROTEOBACTERIA; REVIEW; VAGINITIS; VERRUCOMICROBIA; ANIMAL; GASTROINTESTINAL TRACT; IMMUNOLOGY; METABOLIC DISORDER; METABOLISM; MICROBIOLOGY;

ANIMALS; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION; METABOLIC DISEASES;

EID: 84961794999     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/bm2015.0062     Document Type: Review

References (117)

1. Amar, J., Burcelin, R., Ruidavets, J.B., Cani, P.D., Fauvel, J., Alessi, M.C., Chamontin, B. and Ferrieres. J. 2008. Energy intake is associated with endotoxemia in apparently healthy men. American Journal of Clinical Nutrition 87: 1219-1223.
2. Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D.R. and Fernandes, G.R., 2011. Enterotypes of the human gut microbiome. Nature 473: 174-180.
3. Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., Taniguchi, T., Takeda, K., Hori, S., Ivanov, I.I., Umesaki, Y., Itoh, K. and Honda, K., 2011. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331: 337-341.
4. Ayabe, T., Satchell, D.P., Wilson, C.L., Parks, W.C., Selsted, M.E. and Ouellette, AJ., 2000. Secretion of microbicidal alpha-defensins by intestinal paneth cells in response to bacteria. Nature Immunology 1: 113-118.
5. Backhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A., Semenkovich, C.F. and Gordon, J.I., 2004. The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the USA 101: 15718-23.
6. Backhed, F., Manchester, J.K., Semenkovich, C.F. and Gordon, J.I., 2007. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proceedings of the National Academy of Sciences of the USA 104: 979-984.
7. Backhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva-Datchary, P., Li, Y., Xia, Y., Xie, H., Zhong, H., Khan, M.T., Zhang, J., Li, J., Xiao, L., Al-Aama, J., Zhang, D., Lee, Y.S., Kotowska, D., Colding, C., Tremaroli, V., Yin, Y., Bergman, S., Xu, X., Madsen, L., Kristiansen, K., Dahlgren, J. and Wang, J., 2015. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17: 690-703.
8. Belenguer, A., Duncan, S.H., Calder, A.G., Holtrop, G., Louis, P., Lobley, G.E. and Flint, H.J., 2006. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Applied and Environmental Microbiology 72: 3593-3599.
9. Bergstrom, A., Skov, T.H., Bahl, M.I., Roager, H.M., Christensen, L.B., Ejlerskov, K.T., Molgaard, C., Michaelsen, K.F. and Licht, T.R., 2014. Establishment of intestinal microbiota during early life: A longitudinal, explorative study of a large cohort of Danish infants. Applied and Environmental Microbiology.
10. Bjorksten, B., Sepp, E., Julge, K., Voor, T. and Mikelsaar, M., 2001. Allergy development and the intestinal microflora during the first year of life. Journal of Allergy and Clinical Immunology 108: 516-520.
11. Blaschitz, C. and Raffatellu, M., 2010. Th17 cytokines and the gut mucosal barrier. Journal of Clinical Immunology 30: 196-203.
12. Boleij, A. and Tjalsma, H., 2012. Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer. Biological reviews of the Cambridge Philosophical Society 87: 701-730.
13. Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A.M., Fava, F., Tuohy, K.M., Chabo, C., Waget, A., Delmée, E., Cousin, B., Sulpice, T., Chamontin, B., Ferrières, J., Tanti, J, F., Gibson, G.R., Casteilla, L., Delzenne, N.M. and Alessi, M.C., 2007a. Burcelin r. metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772.
14. Cani, P.D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A.M., Delzenne, N.M. and Burcelin, R., 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat dietinduced obesity and diabetes in mice. Diabetes 57: 1470-1481.
15. Cani, P.D., Hoste, S., Guiot, Y. and Delzenne, N.M., 2007b. Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. British Journal of Nutrition 98: 32-37.
16. Cani, P.D., Knauf, C., Iglesias, M.A., Drucker, D.J., Delzenne, N.M. and Burcelin, R., 2006. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagonlike peptide1receptor. Diabetes 55: 1484-1490.
17. Cani, P.D., Lecourt, E., Dewulf, E.M., Sohet, F.M., Pachikian, B.D., Naslain, D., De Backer, F., Neyrinck, A.M. and Delzenne, N.M., 2009a. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. American Journal of Clinical Nutrition 90: 1236-1243.
18. Cani, P.D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D.M., Muccioli, G.G. and Delzenne N.M., 2009b. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58: 1091-1103.
19. Carding, S., Verbeke, K., Vipond, D.T., Corfe, B.M. and Owen, L. J., 2015. Dysbiosis of the gut microbiota in disease. Microbial Ecology in Health and Disease 26: 26191.
20. Childs, C.E., Röytiö, H., Alhoniemi, E., Fekete, A.A., Forssten, S.D., Hudjec, N., Lim, Y.N., Steger, C.J., Yaqoob, P., Tuohy, K.M., Rastall, R.A., Ouwehand, A.C. and Gibson, G.R., 2014. Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study. British Journal of Nutrition 24: 1-12.
21. Clarke S.F., Murphy, E.F., O'Sullivan, O., Lucey, A.J., Humphreys, M., Hogan, A., Hayes, P., O'Reilly, M., Jeffery, I.B., Wood-Martin, R., Kerins, D.M., Quigley, E., Ross, R.P., O'Toole, P.W., Molloy, M.G., Falvey, E., Shanahan, F., and Cotter, P.D., 2014. Exercise and associated dietary extremes impact on gut microbial diversity. Gut 63: 1913-1920.
22. Clarke, T.B., Davis, K.M., Lysenko, E.S., Zhou, A.Y., Yu, Y. and Weiser, J.N., 2010. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nature Medicine 16: 228-231.
23. Cox, L.M., Yamanishi, S., Sohn, J., Alekseyenko, A.V., Leung, J.M., Cho, I., Kim, S.G., Li, H., Gao, Z., Mahana, D., Zárate, J.G., Rogers, A.B., Robine, N., Loke, P. and Blaser, M.J., 2014. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158: 705-721.
24. Davenport, E.R., Mizrahi-Man, O., Michelini, K., Barreiro, L.B., Ober, C. and Gilad, Y., 2014. Seasonal variation in human gut microbiome composition. PLoS One 9: e90731.
25. David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., Ling, A.V., Devlin, A.S., Varma, Y., Fischbach, M.A., Biddinger, S.B., Dutton, R.J. and Turnbaugh, P.J., 2014. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505: 559-563.
26. Dethlefsen, L., Eckburg, P. B., Bik, E.M. and Relman, D.A., 2006. Assembly of the human intestinal microbiota. Trends in Ecology and Evolution 21: 517-523.
27. Ding, S., Chi, M.M., Scull, B.P., Rigby, R., Schwerbrock, N.M., Magness, S., Jobin, C. and Lund, P.K., 2010. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One 5: e12191.
28. Dridi, B., M. Henry, Khéchine, E.L., Raoult, D. and Drancourt, M., 2009. High prevalence of Methanobrevibacter smithii and Methanosphaera stadtmanae detected in the human gut using an improved DNA detection protocol. PLoS One 4: e7063.
29. Duncan, S. H., P. Louis. and Flint, H.J., 2004. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Applied and Environmental Microbiology 70: 5810-5817.
30. Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S.R., Nelson, K.E. and Relman, D.A., 2005. Diversity of the human intestinal microbial flora. Science 308: 1635-1638.
31. Elinav, E., Strowig, T., Kau, A.L., Henao-Mejia, J., Thaiss, C.A., Booth, C.J., Peaper, D.R., Bertin, J., Eisenbarth, S.C., Gordon, J.I. and Flavell, R.A., 2011. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145: 745-757.
32. Endesfelder, D., Castell, W.Z., Ardissone, A., Davis-Richardson, A.G., Achenbach, P., Hagen, M., Pflueger, M., Gano, K.A., Fagen, J.R., Drew, J.C., Brown, C.T., Kolaczkowski, B., Atkinson, M., Schatz, D., Bonifacio, E., Triplett, E.W. and Ziegler, A.G., 2014. Compromised gut microbiota networks in children with anti-islet cell autoimmunity. Diabetes 63: 2006-2014.
33. Erejuwa, O.O., Sulaiman, S.A. and Wahab, M.S., 2014. Modulation of gut microbiota in the management of metabolic disorders: the prospects and challenges. International Journal of Molecular Science 15: 4158-4188.
34. Faith, J.J., Guruge, J.L., Charbonneau, M., Subramanian, S., Seedorf, H., Goodman, A.L., Clemente, J.C., Knight, R., Heath, A.C., Leibel R.L., Rosenbaum, M. and Gordon, J.I., 2013. The long-term stability of the human gut microbiota. Science 341: 1237439.
35. Flint, H.J., Duncan, S.H., Scott, K.P. and Louis, P., 2007. Interactions and competition within the microbial community of the human colon: links between diet and health. Environmental Microbiology 9: 1101-1111.
36. Fritz, J.H., Le Bourhis, L., Sellge, G., Magalhaes, J.G., Fsihi, H. and Kufer, T.A., 2007. Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 26: 445-459.
37. Fuller, R., 1989. Probiotics in man and animals. Journal of Applied Bacteriology 66: 365-378.
38. Furet, J.P., Kong, L.C., Tap, J., Poitou, C., Basdevant, A., Bouillot, J.L., Mariat, D., Corthier, G., Dore, J., Henegar, C., Rizkalla, S. and Clément, K., 2010. Differential adaptation of human gut microbiota to bariatric surgery induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 59: 3049-3057.
39. Gangloff, S.C., Hijiya, N., Haziot, A. and Goyert, S.M., 1999. Lipopolysaccharide structure influences the macrophage response via CD14-independent and CD14-dependent pathways. Clinical Infectious Diseases 28: 491-496.
40. Ghanim, H., Abuaysheh, S., Sia, C.L., Korzeniewski, K., Chaudhuri, A., Fernandez-Real, J.M. and Dandona, P., 2009. Increase in plasma endotoxin concentrations and the expression of toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 32: 2281-2287.
41. Ghanim, H., Sia, C.L., Upadhyay, M., Korzeniewski, K., Viswanathan, P., Abuaysheh, S., Mohanty, P. and Dandona, P., 2010. Orange juice neutralizes the proinflammatory effect of a high-fat, highcarbohydrate meal and prevents endotoxin increase and toll-like receptor expression. American Journal of Clinical Nutrition 91: 940-949.
42. Ghoshal, S., Witta, J., Zhong, J., De Villiers, W. and Eckhardt, E., 2009. Chylomicrons promote intestinal absorption of lipopolysaccharides. Journal of Lipid Research 50: 90-97.
43. Gibson, G.R. and Roberfroid, M.B., 1995. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. Journal of Nutrition 125: 1401-1412.
44. Gill, S.R., Pop, M., Deboy, R.T., Eckburg, P.B., Turnbaugh, P.J., Samuel, B.S., Gordon, J.I., Relman, D.A., Fraser-Liggett, C.M. and Nelson, K.E., 2006. Metagenomic analysis of the human distal gut microbiome. Science 312: 1355-1359.
45. Gonzalez-Navajas, J.M., Bellot, P., Francés, R., Zapater, P., Muñoz, C., García-Pagán, J.C., Pascual, S., Pérez-Mateo, M., Bosch, J. and Such, J., 2008. Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin. Journal of Hepatology 48: 61-67.
46. Graessler, J., Qin, Y., Zhong, H., Zhang, J., Licinio, J., Wong, M.L., Xu, A., Chavakis, T., Bornstein, A.B., Ehrhart-Bornstein, M., Lamounier-Zepter, V., Lohmann, T., Wolf, T. and Bornstein, S.R., 2012. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenomics Journal 13: 514-522.
47. Guida, S and Venema, K., 2015. Gut microbiota and obesity: involvement of the adipose tissue. Journal of Functional Foods 14: 407-423.
48. Harmsen, H.J., Wildeboer-Veloo, A.C., Wagendorp, A.A., Bindels, J.G. and Welling, G.W., 2000. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. Journal of Pediatric Gastroenterology and Nutrition 30: 61-67.
49. Hentges, D.J., 1993. The anaerobic microflora of the human-body. Clinical Infectious Diseases 16: S175-S180.
50. Hold, G.L., Smith, M., Grange, C., Watt, E.R., El-Omar, E.M. and Mukhopadhya, I., 2014. Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? World Journal of Gastroenterology 20: 1192-1210.
51. Kalliomaki, M., Collado, M.C., Salminen, S. and Isolauri, E., 2008. Early differences in fecal microbiota composition in children may predict overweight. American Journal of Clinical Nutrition 87: 534-538.
52. Kelishadi, R., Farajian, S., Safavi, M., Mirlohi, M. and Hashemipour, M., 2014. A randomized triple-masked controlled trial on the effects of synbiotics on inflammation markers in overweight children. Journal of Paediatrics 90: 161-168.
53. Khosravi, A. and Mazmanian, S.K., 2013. Disruption of the gut microbiome as a risk factor for microbial infections. Current Opinions in Microbiology 16: 221-227.
54. Khosravi, A., Yanez, A., Price, J.G., Chow, A., Merad, M., Goodridge, H.S. and Mazmanian, S.K., 2014. Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host Microbe 15: 374-381.
55. King, S., Glanville, J., Sanders, M.E., Fitzgerald, A. and Varley, D., 2014. Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: a systematic review and meta-analysis. British Journal of Nutrition 29: 1-14.
56. Konig, J. and Brummer, R.J., 2014. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome. Beneficial Microbes 5: 247-261.
57. Kumar, M., Kumar, A., Nagpal, R., Mohania, D., Behare, P., Verma, V., Kumar, P., Poddar, D., Aggarwal, P.K., Henry, C.J, Jain, S. and Yadav, H., 2010. Cancer-preventing attributes of probiotics: an update. International Journal of Food Science and Nutrition 61: 473-496.
58. Kumar, M., Nagpal, R., Kumar, R., Hemalatha, R., Verma, V., Kumar, A., Chakraborty, C., Singh, B., Marotta, F., Jain, S. and Yadav, H., 2012a. Cholesterol lowering probiotics as potential biotherapeutics for metabolic diseases. Experimental Diabetes Research 2012: 902917.
59. Kumar, M., Nagpal, R., Verma, V., Kumar, A., Kaur, N., Hemalatha, R., Gautam, S. and Singh, B., 2013a. The probiotic metabolites as epigenetic target to control colon cancer. Nutrition Reviews 71: 23-34.
60. Kumar, M., Rakesh, S., Nagpal, R., Kumar, R., Hemalatha, R., Ramakrishna, A., Sudarshan, V., Ramagoni, R., Shujauddin, M., Verma, V., Kumar, A., Tiwari, A. and Singh, B., 2013b. Probiotic Lactobacillus rhamnosus GG and Aloe vera gel improves lipid profiles in hypercholesterolemic rats. Nutrition 29: 574-579.
61. Kumar, M., Verma, V., Nagpal, R., Kumar, A., Behare, P.V., Singh, B. and Aggarwal, P.K., 2012b. Anticarcinogenic effect of probiotic fermented milk and chlorophyllin on aflatoxin-B1 induced liver carcinogenesis in rats. British Journal of Nutrition 107: 1006-1016.
62. Kumar, M., Verma, V., Nagpal, R., Kumar, A., Gautam, S.K., Behare, P.V., Grover, C.R. and Aggarwal, P.K., 2011. Effect of probiotic fermented milk and chlorophyllin on gene expressions and genotoxicity during AFB1-induced hepatocellular carcinoma. Gene 490: 54-59.
63. Kunisawa, J. and Kiyono, H., 2012. Immune regulation and monitoring at the epithelial surface of the intestine. Drug Discovery Today 18: 87-92.
64. Lee, C.Y., 2013. The effect of high-fat diet-induced pathophysiological changes in the gut on obesity: what should be the ideal treatment? Clinical and Translational Gastroenterology 11: 4.
65. Ley, R.E., 2010. Obesity and the human microbiome. Current Opinions in Gastroenterology 26: 5-11.
66. Ley, R.E., Backhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D. and Gordon, J.I., 2005. Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the USA 102: 11070-11075.
67. Ley, R.E., Turnbaugh, P.J., Klein, S. and Gordon, J.I. 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022-1023.
68. Lozupone, C., Stombaugh, J., Gonzalez, A., Ackermann, G., Wendel, D., Vázquez-Baeza, Y., Jansson, J.K., Gordon, J.I. and Knight, R., 2013. Meta-analyses of studies of the human microbiota. Genome Research 23: 1704-1714.
69. Lundell, A.C., Rabe, H., Quiding-Järbrink, M., Andersson, K., Nordström, I., Adlerberth, I., Wold, A.E. and Rudin, A., 2011. Development of gut-homing receptors on circulating B cells during infancy. Clinical Immunology 138: 97-106.
70. Ma, J., Prince, A.L., Bader, D., Hu, M., Ganu, R., Baquero, K., Blundell, P., Alan Harris, R., Frias, A.E., Grove, K.L. and Aagaard, K.M., 2014. High-fat maternal diet during pregnancy persistently alters the offspring microbiome in a primate model. Nature Communications 20: 3889.
71. Macfarlane, G.T. and Macfarlane, S., 2007. Models for intestinal fermentation: association between food components, delivery systems, bioavailability and functional interactions in the gut. Current Opinions in Biotechnology 18: 156-162.
72. Macfarlane, G.T., Cummings J.H. and Allison, C., 1986. Protein-Degradation by human intestinal bacteria. Journal of General Microbiology 132: 1647-1656.
73. Macfarlane, S., Bahrami, B. and Macfarlane, G.T., 2011. Mucosal biofilm communities in the human intestinal tract. Advances in Applied Microbiology 75: 111-143.
74. Macfarlane, S., Steed, H. and Macfarlane, G.T., 2009. Intestinal bacteria and inflammatory bowel disease. Critical Reviews in Clinical Laboratory Science 46: 25-54.
75. Mayer, E.A., Savidge, T. and Shulman, R.J., 2014. Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology 146: 1500-1512.
76. Menard, S., Förster, V., Lotz, M., Gütle, D., Duerr, C.U., Gallo, R.L., Henriques-Normark, B., Pütsep, K., Andersson, M., Glocker, E.O. and Hornef, M.W., 2008. Developmental switch of intestinal antimicrobial peptide expression. Journal of Experimental Medicine 205: 183-193.
77. Metchnikoff, E., 1907. The prolongation of life. Optimistic studies. William Heinemann, London, UK.
78. Muccioli, G.G., Naslain, D., Bäckhed, F., Reigstad, C.S, Lambert, D.M., Delzenne, N.M and Cani, P.D., 2010. The endocannabinoid system links gut microbiota to adipogenesis. Molecular Systems Biology 6: 392.
79. Musso, G., Gambino, R. and Cassader, M., 2011. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annual Reviews in Medicine 62: 361-380.
80. Myles, I.A., Pincus, N.B., Fontecilla, N.M. and Datta, S.K., 2014. Effects of parental omega-3 fatty acid intake on offspring microbiome and immunity. PLoS One 9: e87181.
81. Nagpal, R., Kumar, A., Kumar, M., Behare, P.V., Jain, S. and Yadav, H., 2012. Probiotics, their health benefits and applications for developing healthier foods: a review. FEMS Microbiology Letters 334: 1-15.
82. Nagpal, R., Yadav, H. and Marotta, F., 2014. Gut microbiota: the nextgen frontier in preventive and therapeutic medicine? Frontiers in Medicine 1: 15.
83. Nagpal, R., Yadav, H., Puniya, A.K., Singh, K., Jain, S. and Marotta, F., 2007. Potential of probiotics and prebiotics for synbiotic functional dairy foods. International Journal of Probiotics and Prebiotics 2: 75-84.
84. Neufeld, K.M., Kang, N., Bienenstock, J. and Foster, J.A., 2011. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterology and Motility 23: 255-264.
85. Png, C.W., Lindén, S.K., Gilshenan, K.S., Zoetendal, E.G., McSweeney, C.S., Sly, L.I., McGuckin, M.A. and Florin, T.H., 2010. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. American Journal of Gastroenterology 105: 2420-2428.
86. Podolsky, D.K., 1991. Inflammatory bowel disease (1). New England Journal of Medicine 325: 928-937.
87. Rabot, S., Membrez, M., Bruneau, A., Gérard, P., Harach, T., Moser, M., Raymond, F., Mansourian, R. and Chou, C.J., 2010. Germfree C57BL/6J mice are resistant to high-fat-diet induced insulin resistance and have altered cholesterol metabolism. FASEB Journal 24: 4948-4959.
88. Rajilic-Stojanovic, M., Smidt, H. and De Vos, W.M., 2007. Diversity of the human gastrointestinal tract microbiota revisited. Environmental Microbiology 9: 2125-2136.
89. Robert, C. and Bernalier-Donadille, A., 2003. The cellulolytic microflora of the human colon: evidence of microcrystalline cellulose-degrading bacteria in methane-excreting subjects. FEMS Microbiology and Ecology 46: 81-89.
90. Rossi, O., Van Baarlen, P. and Wells, J.M., 2013. Host-recognition of pathogens and commensals in the mammalian intestine. Current Topics in Microbiology and Immunology 358: 291-321.
91. Salazar, N., Dewulf, E.M., Neyrinck, A.M., Bindels, L.B., Cani, P.D., Mahillon, J., De Vos, W.M., Thissen, J.P., Gueimonde, M., De los Reyes-Gavilán, C.G. and Delzenne, N.M., 2014. Inulin-type fructans modulate intestinal Bifidobacterium species populations and decrease fecal short-chain fatty acids in obese women. Clinical Nutrition 34: 501-507.
92. Salminen, S., Gibson, G.R., McCartney A.L. and Isolauri, E., 2004. Influence of mode of delivery on gut microbiota composition in seven year old children. Gut 53: 1388-1389.
93. Samuel, B.S., Shaito, A., Motoike, T., Rey, F.E., Backhed, F., Manchester, J.K., Hammer, R.E., Williams, S.C., Crowley, J., Yanagisawa, M. and Gordon, J.I., 2008. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein coupled receptor, Gpr41. Proceedings of the National Academy of Sciences of the USA 105: 16767-16772.
94. Sato, J., Kanazawa, A., Ikeda, F., Yoshihara, T., Goto, H., Abe, H., Komiya, K., Kawaguchi, M., Shimizu, T., Ogihara, T., Tamura, Y., Sakurai, Y., Yamamoto, R., Mita, T., Fujitani, Y., Fukuda, H., Nomoto, K., Takahashi, T., Asahara, T., Hirose, T., Nagata, S., Yamashiro, Y. and Watada, H., 2014. Gut dysbiosis and detection of 'live gut bacteria' in blood of Japanese patients with type 2 diabetes. Diabetes Care 37: 2343-2350.
95. Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N.A., Donus, C. and Hardt, P.D., 2010. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18: 190-195.
96. Sekirov, I., Russell, S.L., Antunes, L.C. and Finlay, B.B., 2010. Gut microbiota in health and disease. Physiological Reviews 90: 859-904.
97. Shi, H., Kokoeva, M.V., Inouye, K., Tzameli, I., Yin, H. and Flier, J.S., 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. Journal of Clinical Investigations 116: 3015-3025
98. Sokol, H., Lay, C., Seksik, P. and Tannock, G.W., 2008. Analysis of bacterial bowel communities of IBD patients: what has it revealed? Inflammatory Bowel Diseases 14: 858-867.
99. Sokol, H., Seksik, P., Furet, J.P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P. and Doré, J., 2009. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflammatory Bowel Diseases 15: 1183-1189.
100. Soyucen, E., Gulcan, A., Aktuglu-Zeybek, A.C., Onal, H., Kiykim, E. and Aydin, A., 2013. Differences in the gut microbiota of healthy children and those with type 1 diabetes. Pediatrics International 56: 336-343.
101. Spruss, A., Kanuri, G., Wagnerberger, S., Haub, S., Bischoff, S.C. and Bergheim, I., 2009. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 50: 1094-1104.
102. Stefka, A.T., Feehley, T., Tripathi, P., Qiu, J., McCoy, K., Mazmanian, S.K., Tjota, M.Y., Seo, G.Y., Cao, S., Theriault, B.R., Antonopoulos, D.A., Zhou, L., Chang, E.B., Fu, Y.X., Nagler, C.R., 2014. Commensal bacteria protect against food allergen sensitization. Proceedings of the National Academy of Sciences of the USA 111: 13145-13150.
103. Tannock, G.W., 2002. The bifidobacterial and Lactobacillus microflora of humans. Clinical Reviews in Allergy and Immunology 22: 231-253.
104. Tremaroli, V. and Backhed, F., 2012. Functional interactions between the gut microbiota and host metabolism. Nature 489: 242-249.
105. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R. and Gordon, J.I., 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
106. Vaarala, O., Atkinson, M.A., Neu, J., 2008. The 'perfect storm' for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57: 2555-2562.
107. Van den Abbeele, P., Van de Wiele, T., Verstraete, W. and Possemiers, S., 2011. The host selects mucosal and luminal associations of coevolved gut microorganisms: a novel concept. FEMS Microbiology Reviews 35: 681-704.
108. Vijay-Kumar, M., Aitken, J.D., Carvalho, F.A., Cullender, T.C., Mwangi, S. and Srinivasan, S., 2010. Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5. Science 328: 228-231.
109. Wallace, T.C., Guarner, F., Madsen, K., Cabana, M.D., Gibson, G., Hentges, E. and Sanders, M.E., 2011. Human gut microbiota and its relationship to health and disease. Nutrition Reviews 69: 392-403.
110. Woodmansey, E.J., 2007. Intestinal bacteria and ageing. Journal of Applied Microbiology 102 1178-1186.
111. Xavier, R.J. and Podolsky, D.K., 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434.
112. Yadav, H., Jain, S. and Sinha, P.R., 2007. Antidiabetic effect of probiotic Dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 23: 62-68.
113. Yadav, H., Jain, S. and Sinha, P.R., 2008. Oral administration of Dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats. Journal of Dairy Research 75: 189-195.
114. Yadav, H., Lee, J.H., Lloyd, J., Walter, P. and Rane, S.G., 2013. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. Journal of Biological Chemistry 288: 25088-25097.
115. Zeng, H., Lazarova, D.L. and Bordonaro, M., 2014. Mechanisms linking dietary fiber, gut microbiota and colon cancer prevention. World Journal of Gastrointestinal Oncology 6: 41-51.
116. Zhou, J., Martin, R.J., Tulley, R.T., Raggio, A.M., McCutcheon, K.L., Shen, L., Danna, S.C., Tripathy, S., Hegsted, M. and Keenan, M.J., 2008. Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. The American Journal of Physiology: Endocrinology and Metabolism 295: E1160-E1166.
117. Zoetendal, E.G., Akkermans, A.D.L., Vliet, W.M.A., Visser, J.A.G M. and De Vos, W.M., 2001. The host genotype affects the bacterial community in the human gastronintestinal tract. Microbiology and Ecology in Health and Disease 13: 129-134.